675
Participants
Start Date
January 24, 2023
Primary Completion Date
March 19, 2024
Study Completion Date
January 27, 2025
TV-44749 - Dose level 1
In Period 1, 2 monthly injections. In Period 2, up to 12 monthly injections
TV-44749 - Dose level 2
In Period 1, 2 monthly injections, In Period 2 up to 12 monthly injections
TV-44749 - Dose level 3
In Period 1, 2 monthly injections. In Period 2, up to 12 monthly injections
Placebo
In Period 1, 2 monthly injections (Period 1 only)
Teva Investigational Site 59205, Sofia
Teva Investigational Site 59212, Sofia
Teva Investigational Site 59206, Vratsa
Teva Investigational Site 59207, Plovdiv
Teva Investigational Site 59209, Veliko Tarnovo
Teva Investigational Site 59208, Lovech
Teva Investigational Site 59214, Pleven
Teva Investigational Site 82059, Ankara
Teva Investigational Site 59203, Kazanlak
Teva Investigational Site 59202, Rousse
Teva Investigational Site 59215, Razgrad
Teva Investigational Site 59210, Burgas
Teva Investigational Site 59211, Sliven
Teva Investigational Site 52127, Bucharest
Teva Investigational Site 82057, Bursa
Teva Investigational Site 15442, Gaithersburg
Teva Investigational Site 15441, Charlotte
Teva Investigational Site 15469, Decatur
Teva Investigational Site 15500, Peachtree Corners
Teva Investigational Site 15468, Atlanta
Teva Investigational Site 15494, Miami Lakes
Teva Investigational Site 15457, Hialeah
Teva Investigational Site 15467, Miami Lakes
Teva Investigational Site 15473, Miami Lakes
Teva Investigational Site 15488, Hollywood
Teva Investigational Site 15498, Hollywood
Teva Investigational Site 15458, Hollywood
Teva Investigational Site 15489, Homestead
Teva Investigational Site 15452, Miami
Teva Investigational Site 15495, Miami
Teva Investigational Site 15446, Miami
Teva Investigational Site 15456, Miami
Teva Investigational Site 15479, Miami
Teva Investigational Site 15484, Miami Springs
Teva Investigational Site 15462, Miami
Teva Investigational Site 15477, West Palm Beach
Teva Investigational Site 15466, Flowood
Teva Investigational Site 15472, North Canton
Teva Investigational Site 15454, Dayton
Teva Investigational Site 82058, Adapazarı
Teva Investigational Site 15485, Chicago
Teva Investigational Site 15480, Chicago
Teva Investigational Site 15487, St Louis
Teva Investigational Site 15447, Shreveport
Teva Investigational Site 15465, Little Rock
Teva Investigational Site 15460, Bentonville
Teva Investigational Site 15453, Rogers
Teva Investigational Site 15478, Oklahoma City
Teva Investigational Site 15464, Irving
Teva Investigational Site 15443, Richardson
Teva Investigational Site 15486, DeSoto
Teva Investigational Site 15448, Austin
Teva Investigational Site 15497, Los Angeles
Teva Investigational Site 15483, Torrance
Teva Investigational Site 15474, La Habra
Teva Investigational Site 15455, Pico Rivera
Teva Investigational Site 15459, Bellflower
Teva Investigational Site 15491, Long Beach
Teva Investigational Site 15461, Sherman Oaks
Teva Investigational Site 15482, Los Angeles
Teva Investigational Site 15481, Lemon Grove
Teva Investigational Site 15449, Santee
Teva Investigational Site 15444, San Diego
Teva Investigational Site 15471, Riverside
Teva Investigational Site 15470, Anaheim
Teva Investigational Site 15490, Garden Grove
Teva Investigational Site 15450, Orange
Teva Investigational Site 88052, Beijing
Teva Investigational Site 88053, Shanghai
Teva Investigational Site 88060, Hefei
Teva Investigational Site 88055, Jining Shi
Teva Investigational Site 88054, Tianjin
Teva Investigational Site 88044, Hangzhou
Teva Investigational Site 88068, Nanchangshi
Teva Investigational Site 88071, Wuhan
Teva Investigational Site 88072, Xinxiang
Teva Investigational Site 88064, Zhumadian
Teva Investigational Site 52123, Iași
Teva Investigational Site 52126, Iași
Teva Investigational Site 15496, Miami
Teva Investigational Site 15451, Marlton
Teva Investigational Site 52124, Bucharest
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY